Product
Allo-HSCT
1 clinical trial
1 indication
Indication
Hurler SyndromeClinical trial
A Multi-center, Randomized, Active Controlled Clinical Trial to Evaluate the Efficacy and Safety of OTL-203 in Subjects With Mucopolysaccharidosis Type I, Hurler Syndrome (MPS-IH) Compared to Standard of Care With Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)Status: Recruiting, Estimated PCD: 2028-03-01